Page 1

EX - 99.1 2 d212310dex991.htm EX - 99.1 FOR MORE INFORMATION : Charles Lynch Senior Vice President , Finance and Strategy 954-384-0175 , x 5692 charles_lynch@mednax.com FOR IMMEDIATE RELEASE MEDNAX® National Medical Group Exhibit 99.1 Mednax Reports Second Quarter Results FORT LAUDERDALE , Fla . , August 6 , 2021 - Mednax , Inc. ( NYSE : MD ) , the national medical group specializing in prenatal , neonatal , and pediatric services , today reported earnings from continuing operations of $ 0.36 per share for the three months ended June 30 , 2021. On a non - GAAP basis , Mednax reported Adjusted EPS from continuing operations of $ 0.41 . For the 2021 second quarter , Mednax reported the following results from continuing operations : • Net revenue of $ 473 million ; • Income from continuing operations of $ 31 million ; and • Adjusted EBITDA of $ 66 million . " Strong patient volume trends across the spectrum of our service lines provided the foundation for strong second quarter results , " said Mark S. Ordan , Chief Executive Officer of Mednax . " We believe these trends , combined with our focus on women's and children's care , operating efficiency and growth in many areas of pediatric subspecialty services , together put us on a very positive forward path . " Operating Results from Continuing Operations - Three Months Ended June 30 , 2021 Mednax's net revenue for the three months ended June 30 , 2021 was $ 473.0 million , compared to $ 415.4 million for the prior - year period . Mednax's overall same - unit revenue increased by 13.4 percent , slightly complemented by net acquisition activity . Same - unit revenue attributable to patient volume increased by 9.5 percent for the 2021 second quarter as compared to the prior - year period . Shown below are year - over - year percentage changes in certain same - unit volume statistics for the three and six months ended June 30 , 2021 .